EBITDA (Quarterly)

EBITDA: Income before interest, taxes, depreciation and amortization.

Treace Medical Concepts, Inc. (TMCI) had EBITDA of $-14.36M for the most recently reported fiscal quarter, ending 2025-06-30.

Quarterly Annual

Figures for fiscal quarter ending 2025-06-30

Income Statement Financials
Revenue	$47.39M
Net Income	$-17.40M
Cost of Goods Sold	$9.63M
Gross Profit	$37.75M
Operating Expenses	$64.36M
Operating Income	$-16.97M
Non-Operating Income/Expense	$-0.42M
Pre-Tax Income	$-17.40M
Normalized Pre-Tax Income	$-17.40M
Income after Taxes	$-17.40M
Income from Continuous Operations	$-17.40M
Consolidated Net Income/Loss	$-17.40M
Normalized Income after Taxes	$-17.40M
EBIT	$-16.97M
EBITDA	$-14.36M
Weighted-Average Shares Outstanding (Basic)	63.01M
Weighted-Average Shares Outstanding (Diluted)	63.01M
Earnings per Share (EPS) (Basic)	$-0.28
Earnings per Share (EPS) (Diluted)	$-0.28
Balance Sheet Financials
Current Assets	$147.60M
Property, Plant, and Equipment	$29.71M
Long-Term Assets	$58.84M
Total Assets	$206.44M
Current Liabilities	$41.90M
Long-Term Debt	$53.45M
Long-Term Liabilities	$66.93M
Total Liabilities	$108.83M
Common Equity	$97.61M
Tangible Shareholders Equity	$77.20M
Shareholders Equity	$97.61M
Common Shares Outstanding	63.04M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$1.15M
Cash Flow from Investing Activities	$-5.15M
Cash Flow from Financial Activities	$0.70M
Beginning Cash	$11.35M
End Cash	$8.05M
Increase/Decrease in Cash	$-3.30M
Stock-Based Compensation	$18.27M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	3.52
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.35
Debt to Equity Ratio	0.55
Gross Margin	79.67%
Operating Margin	-35.82%
EBIT Margin	-35.82%
EBITDA Margin	--
Pre-Tax Profit Margin	-36.71%
Profit Margin	-36.71%
Free Cash Flow	$-7.16M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.23
Inventory Turnover	0.23
Receiveable Turnover	1.56
Days Sales in Receivables	57.61
Return on Equity	-17.82%
Return on Tangible Equity	-22.54%
Return on Assets	-8.43%
Return on Investments	-11.52%
Book Value Per Share	$1.55
Free Cash Flow per Share	$-0.11
Operating Cash Flow per Share	$0.02

Data from Zacks Investment Research, Inc.